National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 78345 [2020-26751]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 234 / Friday, December 4, 2020 / Notices
policies and/or programs. This expertise
may include experience in the analysis,
evaluation, and interpretation of
federal/state health or regulatory policy;
(3) Involvement in national, state,
regional, tribal, and/or local efforts to
improve the health status or outcomes
among racial and ethnic minority
populations;
(4) Educational achievement,
professional certification(s) in healthrelated fields (e.g., health professions,
allied health, behavioral health, public
health, health policy and health
administration/management), and
professional experience that will
support the ability to give expert advice
on issues related to improving minority
health and eliminating racial and ethnic
health disparities; and
(5) Expertise in population level
health data for racial and ethnic
minority groups (e.g., survey,
administrative, and/or clinical data).
Desirable Qualifications:
(1) Knowledge and experience in
health care systems, cultural and
linguistic competency, social
determinants of health, evidence-based
research, data collection (e.g., federal,
state, tribal, or local data collection), or
health promotion and disease
prevention; and
(2) Nationally recognized via peerreviewed publications, professional
awards, advanced credentials, or
involvement in national professional
organizations.
Requirements for Nomination
Submission: Nominations should be
typewritten (one nomination per
nominator). Nomination package should
include: (1) A letter of nomination that
clearly states the name and affiliation of
the nominee, the basis for the
nomination (i.e., specific attributes
which qualify the nominee for service in
this capacity), and a statement from the
nominee indicating a willingness to
serve as a member of the Committee; (2)
the nominee’s contact information,
including name, mailing address,
telephone number, and email address;
(3) the nominee’s current curriculum
vitae which should not exceed 10 pages;
and (4) a summary of the nominee’s
experience and qualification relative to
the mandatory professional and
technical criteria listed above. Federal
employees should not be nominated for
consideration of appointment to this
Committee.
Individuals selected for appointment
to the Committee shall be invited to
serve a four-year term. Committee
members will receive a stipend for
attending Committee meetings and
conducting other business in the
interest of the Committee, including per
VerDate Sep<11>2014
18:18 Dec 03, 2020
Jkt 253001
diem and reimbursement for travel
expenses incurred.
The Department makes every effort to
ensure that the membership of an HHS
federal advisory committee is fairly
balanced in terms of points of view
represented to support the committee’s
function. Every effort is made to ensure
a broad representation of individuals are
considered for membership on HHS
federal advisory committees, including
considerations of geographic diversity,
gender, racial and ethnic and minority
groups, and people with disabilities.
Appointment to this Committee shall be
made without discrimination because of
a person’s race, color, religion, sex
(including pregnancy), national origin,
age, disability, or genetic information.
Nominations must state that the
nominee is willing to serve as a member
of ACMH and appears to have no
conflict of interest that would preclude
membership. An ethics review is
conducted for each selected nominee;
therefore, individuals selected for
nomination will be required to provide
detailed information concerning such
matters as financial holdings,
consultancies, and research grants or
contracts to permit evaluation of
possible sources of conflict of interest.
Individuals selected to serve on the
ACMH through the nomination process
will be posted on the OMH website once
selections have been made.
Authority: 42 U.S.C. 300u–6, Section
1707 of the Public Health Service Act,
as amended. The Advisory Committee is
governed by provisions of Public Law
92–463, as amended (5 U.S.C. Appendix
2), which sets forth standards for the
formation and use of advisory
committees.
Dated: November 24, 2020.
Samuel Wu,
CAPT, U.S. Public Health Service, Designated
Federal Officer, Advisory Committee on
Minority Health.
[FR Doc. 2020–26641 Filed 12–3–20; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
78345
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Emergency Awards: Rapid
Investigation of Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV–2) and
Coronavirus Disease 2019 (COVID–19).
Date: December 28–29, 2020.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70,
Rockville, MD 20892, (Virtual Meeting).
Contact Person: Mohammed S. Aiyegbo,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3E70,
Rockville, MD 20852, (301) 761–7106,
mohammed.aiyegbo@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 1, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–26751 Filed 12–3–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\04DEN1.SGM
04DEN1
]]>Agencies
[Federal Register Volume 85, Number 234 (Friday, December 4, 2020)]
[Notices]
[Page 78345]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26751]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Emergency Awards: Rapid
Investigation of Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19).
Date: December 28-29, 2020.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3E70,
Rockville, MD 20892, (Virtual Meeting).
Contact Person: Mohammed S. Aiyegbo, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3E70,
Rockville, MD 20852, (301) 761-7106, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: December 1, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-26751 Filed 12-3-20; 8:45 am]
BILLING CODE 4140-01-P
